Which of the following drug(s) may cause hypertriglyceridemia in enterally fed patients?

Hypertriglyceridemia in enterally fed patients can be influenced by several medications, all of which can lead to elevation in triglyceride levels through different mechanisms.

Cyclosporine, an immunosuppressant, has been reported to cause lipid abnormalities, including increased triglyceride levels. Its mechanism involves altering lipid metabolism and decreasing the clearance of triglycerides.

Corticosteroids, commonly used for their anti-inflammatory and immunosuppressive properties, can also lead to hyperlipidemia. They promote lipolysis and gluconeogenesis, which can increase triglyceride synthesis in the liver, resulting in elevated serum triglyceride levels.

Thiouracil, a medication used to treat hyperthyroidism, can impact lipid metabolism as well. It may increase lipid levels by inhibiting thyroid hormone synthesis, leading to decreased metabolism and clearance of lipids.

Since all these medications can contribute to hypertriglyceridemia through their respective mechanisms, the correct answer encompasses all of them, emphasizing the importance of monitoring triglyceride levels in enterally fed patients who are receiving any of these treatments.